Table 2.
Target | Process | Localization | Organism | Drugs | Reference |
---|---|---|---|---|---|
Alternative oxidase | Electron transport chain | Mitochondria | T. brucei | Aromatic hydroxamates | Menzies et al. (2018) |
Cytochrome b | Electron transport chain | Mitochondria | T. cruzi | GNF7686 | Khare et al. (2015) |
Lanosterol 14-α-demethylase | Ergosterol biosynthesis | Mitochondria and endoplasmatic reticulum | T. cruzi | Posaconazole Ravuconazole |
Morillo et al. (2017); Urbina (2015) |
Trypanothione synthase | Thiol metabolism | Cytoplasm |
T. brucei T. cruzi Leishmania spp. |
Revised in the references | Vazquez et al. (2017); Leroux and Krauth-Siegel (2016); Torrie et al. (2009) |
Trypanothione reductase | Thiol metabolism | Cytoplasm |
T. brucei T. cruzi Leishmania spp. |
Revised in the references | Leroux and Krauth-Siegel (2016); Vazquez et al. (2017); Lu et al. (2013) |
Ornithine decarboxilase | Polyamine metabolism | Cytoplasm | T. brucei | DFMO | Burri and Brun (2003) |
TcPAT12 | Polyamine metabolism | Flagellar pocket | T. cruzi | Isotretinoin ANT4 Triclabendazole Sertaconazole Paroxetine Cisapride |
Alberca et al. (2016); Reigada et al. (2018); Reigada et al. (2017); Dietrich et al. (2018) |
Enolase | Glycolisis | Cytoplasm and cell surface |
T. brucei T. cruzi Leishmania spp. |
Phosphonoacetohydroxamate | Avilan et al. (2011) |
Piruvate kinase | Glycolisis | Cytoplasm | Leishmania spp. | Furanose sugar amino amides | Nowicki et al. (2008) |
Phosphofructokinase | Glycolisis | Glycosome |
T. brucei T. cruzi |
ML251 Furanose sugar amino amides |
Brimacombe et al. (2014); Nowicki et al. (2008) |
Hexokinase | Glycolisis | Glycosome | T. brucei | EbSe Revised in the references |
Lu et al. (2013); Sharlow et al. (2010a,b) |